Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
for Neovascular Age-related Macular Degeneration
Drug: Surabgene Lomparvovec
53 locations incl. Mesa
Sponsor: AbbVie
Sex: All·Age: 50+
Code: NCT07007065·Phase 3·Recruiting